Role of protein kinase D signaling in pancreatic cancer
- 15 December 2010
- journal article
- review article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 80 (12), 1946-1954
- https://doi.org/10.1016/j.bcp.2010.07.002
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (5P30CA16672, P30DK41301, R01DK55003, R01DK56930, R21CA135218, R21CA137292)
- Robert and Janice McNair Foundation
- University of Texas MD Anderson Cancer Center
This publication has 142 references indexed in Scilit:
- Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motilityBMC Chemical Biology, 2010
- Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC‐1 cellsJournal of Cellular Physiology, 2010
- CID755673 enhances mitogenic signaling by phorbol esters, bombesin and EGF through a protein kinase D-independent pathwayBiochemical and Biophysical Research Communications, 2010
- Signal integration by JNK and p38 MAPK pathways in cancer developmentNature Reviews Cancer, 2009
- Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshotNature, 2009
- Regulation of PKD by the MAPK p38δ in Insulin Secretion and Glucose HomeostasisCell, 2009
- PKD prevents H2O2-induced apoptosis via NF-κB and p38 MAPK in RIE-1 cellsBiochemical and Biophysical Research Communications, 2009
- Mitogenic signaling pathways induced by G protein‐coupled receptorsJournal of Cellular Physiology, 2007
- Protein kinase D enzymes are dispensable for proliferation, survival and antigen receptor‐regulated NFκB activity in vertebrate B‐cellsFEBS Letters, 2007
- Protein kinase D regulates basolateral membrane protein exit from trans-Golgi networkNature, 2004